This Article Full Text Full Text (PDF) All Versions of this Article: 22/11/1859    most recent 01.ATV.0000042202.42136.D0v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Adams, M. R. Articles by Williams, J.K. Search for Related Content PubMed PubMed Citation Articles by Adams, M. R. Articles by Williams, J.K. Related Collections Catheter-based coronary and valvular interventions: other Cardiovascular imaging agents/Techniques CT and MRI CV surgery: aortic and vascular disease

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:1859.)
© 2002 American Heart Association, Inc.

Atherosclerosis and Lipoproteins

The Atheroprotective Effect of Dietary Soy Isoflavones in Apolipoprotein E-/- Mice Requires the Presence of Estrogen Receptor-

Michael R. Adams; Deborah L. Golden; Thomas C. Register; Mary S. Anthony; Jeffrey B. Hodgin; Nobuyo Maeda; J. Koudy Williams

From the Department of Pathology/Comparative Medicine (M.R.A., D.L.G., T.C.R., M.S.A., J.K.W.), Wake Forest University Medical Center, Winston-Salem, NC and the Department of Pathology and Laboratory Medicine (J.B.H., N.M.), University of North Carolina, Chapel Hill.

Correspondence to Michael R. Adams, DVM, Department of Pathology/Comparative Medicine, Wake Forest University Medical Center, Medical Center Blvd., Winston-Salem, NC 27157-1040. E-mail madams{at}wfubmc.edu

Objective— Although the mechanisms by which dietary soy inhibits atherosclerosis are unclear, one line of evidence implicates an important role for its phytoestrogenic isoflavones. We sought to determine whether soy isoflavones exert atheroprotective effects through estrogen receptor–dependent processes and, if so, which estrogen receptor subtype (ie, or ß) is involved.

Methods and Results— We compared the effects of diets rich in soy protein that were either isoflavone depleted (0.04 mg/g protein isolate) or isoflavone-replete, or Soy(+IF) (1.72 mg/g protein isolate) in apolipoprotein E–deficient (ee) mice that had been crossed with estrogen receptor-– and -ß–deficient mice to produce double-knockout ee and ßßee mice and (estrogen receptor) wild-type controls (AAee and BBee). Both male and ovariectomized female mice were studied (n=10 to 17 per treatment group; total n=201). After 16 weeks, atherosclerosis was assessed by quantifying the aortic content of esterified cholesterol. Atherosclerosis was reduced 20% to 27% (P<0.05) by Soy(+IF) in ßßee, BBee, and AAee mice but was unaffected in ee mice. The inhibitory effect of Soy(+IF) was unrelated to sex, total plasma cholesterol, VLDL, LDL, and HDL cholesterol.

Conclusions— The results indicate a necessary role for estrogen receptor-–dependent processes in mediating the atheroprotective effects of dietary soy isoflavones.

Key Words: atherosclerosis • soy • mice • phytoestrogens • estrogen receptors

This article has been cited by other articles:

				S. Nagarajan, R. L. Burris, B. W. Stewart, J. E. Wilkerson, and T. M. Badger Dietary Soy Protein Isolate Ameliorates Atherosclerotic Lesions in Apolipoprotein E-Deficient Mice Potentially by Inhibiting Monocyte Chemoattractant Protein-1 Expression J. Nutr., February 1, 2008; 138(2): 332 - 337. [Abstract] [Full Text] [PDF]

				S. Nagarajan, B. W. Stewart, and T. M. Badger Soy Isoflavones Attenuate Human Monocyte Adhesion to Endothelial Cell-Specific CD54 by Inhibiting Monocyte CD11a J. Nutr., September 1, 2006; 136(9): 2384 - 2390. [Abstract] [Full Text] [PDF]

				X. Xia, W. Ling, J. Ma, M. Xia, M. Hou, Q. Wang, H. Zhu, and Z. Tang An Anthocyanin-Rich Extract from Black Rice Enhances Atherosclerotic Plaque Stabilization in Apolipoprotein E-Deficient Mice J. Nutr., August 1, 2006; 136(8): 2220 - 2225. [Abstract] [Full Text] [PDF]

				G. S. Getz and C. A. Reardon Diet and Murine Atherosclerosis Arterioscler. Thromb. Vasc. Biol., February 1, 2006; 26(2): 242 - 249. [Abstract] [Full Text] [PDF]

				M. R. Adams, D. L. Golden, J. K. Williams, A. A. Franke, T. C. Register, and J. R. Kaplan Soy Protein Containing Isoflavones Reduces the Size of Atherosclerotic Plaques without Affecting Coronary Artery Reactivity in Adult Male Monkeys J. Nutr., December 1, 2005; 135(12): 2852 - 2856. [Abstract] [Full Text] [PDF]

				T. C. Register, J. A. Cann, J. R. Kaplan, J. K. Williams, M. R. Adams, T. M. Morgan, M. S. Anthony, R. M. Blair, J. D. Wagner, and T. B. Clarkson Effects of Soy Isoflavones and Conjugated Equine Estrogens on Inflammatory Markers in Atherosclerotic, Ovariectomized Monkeys J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1734 - 1740. [Abstract] [Full Text] [PDF]

				X.-J. Du Gender modulates cardiac phenotype development in genetically modified mice Cardiovasc Res, August 15, 2004; 63(3): 510 - 519. [Abstract] [Full Text] [PDF]

				M. R. Adams, D. L. Golden, A. A. Franke, S. M. Potter, H. S. Smith, and M. S. Anthony Dietary Soy {beta}-Conglycinin (7S Globulin) Inhibits Atherosclerosis in Mice J. Nutr., March 1, 2004; 134(3): 511 - 516. [Abstract] [Full Text] [PDF]

				T. C. Register, M. J. Jayo, and M. S. Anthony Soy Phytoestrogens Do Not Prevent Bone Loss in Postmenopausal Monkeys J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4362 - 4370. [Abstract] [Full Text] [PDF]